NEW YORK (Reuters Health) – The tyrosine-kinase inhibitor pazopanib seems to be a promising option for treating progressive metastatic differentiated thyroid cancer that is unresponsive to radioiodine therapy,…
NEW YORK (Reuters Health) – Delivery of abciximab directly to the intracoronary thrombus in patients with acute coronary syndromes is more effective than intracoronary bolus infusion in reducing…
NEW YORK (Reuters Health) – In children hospitalized with Henoch-Schönlein purpura, or HSP, corticosteroid treatment is associated with a decreased likelihood of several clinically relevant outcomes, according to…
NEW YORK (Reuters Health) – Response rates are higher when bortezomib plus dexamethasone rather than vincristine plus doxorubicin plus dexamethasone (VAD) is used as induction therapy before stem-cell…
NEW YORK (Reuters Health) – Using the rapid-acting insulin analog glulisine instead of regular human insulin at mealtimes improves glycemic control in hospitalized patients with type 2 diabetes,…
NEW YORK (Reuters Health) – The concern about proton pump inhibitors (PPIs) possibly interfering with the efficacy of clopidogrel may be misdirected, according to a new report. It…
NEW YORK (Reuters Health) – The antiplatelet effect of clopidogrel is much reduced in patients undergoing therapeutic hypothermia after cardiac arrest, according to a Norwegian study published online…
NEW YORK (Reuters Health) – Contrary to expectations, antidepressant step therapy protocols appear to increase medical resource use and costs, according to a study conducted by Thomson Reuters…
NEW YORK (Reuters Health) – When patients with rheumatic illnesses and concomitant diabetes are treated with hydroxychloroquine, their HbA1c levels drop significantly. Methotrexate, however, does not have the…
NEW YORK (Reuters Health) – The risk of developing post-pericardiotomy syndrome (PPS) in cardiac surgery patients can be halved by treatment with colchicine, an international team has shown.…